7.0675
0.2375 (3.48%)
0.2375 (3.48%)
Upgrade to Real-Time
Regular Market
| Volume | 88,621 |
|
|||||
| News | - | ||||||
| Day High | 7.25 | Low High |
|||||
| Day Low | 6.83 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BriaCell Therapeutics Corporation | BCTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.2375 | 3.48% | 7.0675 | 14:34:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.83 | 6.83 | 7.25 | 6.83 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 631 | 88,621 | $ 7.04 | $ 624,324 | - | 4.06 - 12.09 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:40:46 | 1 | $ 7.075 | USD |
Period:
Draw Mode:
BriaCell Therapeutics Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 109.67M | 15.52M | 13.38M | $ - | $ - | -3.38 | -4.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 52.53k | - |
BriaCell Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.53 | 7.82 | 6.745 | 7.25 | 179,061 | -0.4625 | -6.14% |
| 1 Month | 5.43 | 7.82 | 5.30 | 6.89 | 271,008 | 1.64 | 30.16% |
| 3 Months | 5.95 | 7.82 | 4.23 | 6.01 | 214,411 | 1.12 | 18.78% |
| 6 Months | 6.56 | 8.37 | 4.23 | 6.38 | 319,837 | 0.5075 | 7.74% |
| 1 Year | 6.23 | 12.09 | 4.06 | 7.40 | 461,396 | 0.8375 | 13.44% |
| 3 Years | 4.24 | 12.47 | 2.8149 | 6.65 | 1,383,814 | 2.83 | 66.69% |
| 5 Years | 4.24 | 12.47 | 2.8149 | 6.65 | 1,383,814 | 2.83 | 66.69% |
BriaCell Therapeutics Description
| BriaCell Therapeutics Corp. is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. BriaCell is conducting a Phase II clinical trial of Bria-IMT in metastatic advanced breast cancer (Fast Track designation from FDA). BriaCell is developing Bria-OTS, a personalized off the shelf immunotherapy for cancer based on matching the patient's HLA type. Enhanced cellular immunotherapies with enhanced potency are under development. |
